International Stem Cell Corp. (ISCO) Offers Stem Cells with Unmatched Advantages
International Stem Cell Corp., based in Oceanside, California, is a stem cell therapeutics company with a powerful new stem cell technology called “parthenogenesis,” which is expected to significantly advance the field of regenerative medicine by addressing the important issue of immune-rejection. Parthenogenetic stem cells are derived from parthenogenetically activated human oocytes, where electrical or chemical stimuli replaces fertilization. Although not derived from fertilized eggs, these activated oocytes can be developed to the blastocyst stage which can give rise to a parthenogenetic stem cell line. Of the several different types of stem cells, parthenogenetic stem cells (hpSCs) offer a unique combination…